Inhibition of human mixed lymphocyte reaction by antibodies to immunoglobulin light chain determinants
Related Experiment Videos
Clinical and Experimental Immunology
|September 1, 1971
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Investigation of factors influencing the immunogenicity of hCG as a potential cancer vaccine.
Clinical and experimental immunology·2018
Lipoxin A4 selectively programs the profile of M2 tumor-associated macrophages which favour control of tumor progression.
International journal of cancer·2016
Mechanisms of autoimmunity: a role for cross-reactive idiotypes.
Immunology today·2014
Anti-idiotypes as surrogate antigens: structural considerations.
Immunology today·2014
Designing a new generation of anti-hCG vaccines for cancer therapy.
Molecular and cellular endocrinology·2006
Vaccines for the control of reproduction--status in mammals, and aspects of comparative interest.
Developments in biologicals·2005
C5aR1 and C5aR2 deficiency confer different degrees of protection against imiquimod-induced psoriasiform dermatitis.
Clinical and experimental immunology·2026
Cross-reactive T cell immunity against novel coronaviruses with pandemic potential, predictable from spike sequence conservation.
Clinical and experimental immunology·2026
Transcriptomic age acceleration is associated with plasmablast-related immune remodeling in IgG4-related disease.
Clinical and experimental immunology·2026
Beyond a covariate: sex as a mechanistic determinant of Immunometabolism.
Clinical and experimental immunology·2026
T cell metabolic ageing as a factor for therapeutic research.
Clinical and experimental immunology·2026
Post-acute infection: before we forget it again.
Clinical and experimental immunology·2026
Economic evaluation of PET-CT in staging and response assessment of patients with diffuse large B-cell lymphoma (DLBCL) in Thailand: a cost-utility analysis.
Cost effectiveness and resource allocation : C/E·2026
Serum Free Light Chains in Lymphoma: A Phenotype-First Framework for Biological Interpretation, Analytical Control, and Clinical Use.
Current oncology (Toronto, Ont.)·2026